Literature DB >> 23475597

Studies to reduce unnecessary medication use in frail older adults: a systematic review.

Jennifer Tjia1, Sarah J Velten, Carole Parsons, Sruthi Valluri, Becky A Briesacher.   

Abstract

BACKGROUND: Overuse of unnecessary medications in frail older adults with limited life expectancy remains an understudied challenge.
OBJECTIVE: To identify intervention studies that reduced use of unnecessary medications in frail older adults. A secondary goal was to identify and review studies focusing on patients approaching end of life. We examined criteria for identifying unnecessary medications, intervention processes for medication reduction, and intervention effectiveness.
METHODS: A systematic review of English articles using MEDLINE, EMBASE, and International Pharmaceutical Abstracts from January 1966 to September 2012. Additional studies were identified by searching bibliographies. Search terms included prescription drugs, drug utilization, hospice or palliative care, and appropriate or inappropriate. A manual review of 971 identified abstracts for the inclusion criteria (study included an intervention to reduce chronic medication use; at least 5 participants; population included patients aged at least 65 years, hospice enrollment, or indication of frailty or risk of functional decline-including assisted living or nursing home residence, inpatient hospitalization) yielded 60 articles for full review by 3 investigators. After exclusion of review articles, interventions targeting acute medications, or studies exclusively in the intensive care unit, 36 articles were retained (including 13 identified by bibliography review). Articles were extracted for study design, study setting, intervention description, criteria for identifying unnecessary medication use, and intervention outcomes.
RESULTS: The studies included 15 randomized controlled trials, 4 non-randomized trials, 6 pre-post studies, and 11 case series. Control groups were used in over half of the studies (n = 20). Study populations varied and included residents of nursing homes and assisted living facilities (n = 16), hospitalized patients (n = 14), hospice/palliative care patients (n = 3), home care patients (n = 2), and frail or disabled community-dwelling patients (n = 1). The majority of studies (n = 21) used implicit criteria to identify unnecessary medications (including drugs without indication, unnecessary duplication, and lack of effectiveness); only one study incorporated patient preference into prescribing criteria. Most (25) interventions were led by or involved pharmacists, 4 used academic detailing, 2 used audit and feedback reports targeting prescribers, and 5 involved physician-led medication reviews. Overall intervention effect sizes could not be determined due to heterogeneity of study designs, samples, and measures.
CONCLUSIONS: Very little rigorous research has been conducted on reducing unnecessary medications in frail older adults or patients approaching end of life.

Entities:  

Mesh:

Year:  2013        PMID: 23475597     DOI: 10.1007/s40266-013-0064-1

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  60 in total

1.  Guidelines for the management of agitation in dementia.

Authors:  R Howard; C Ballard; J O'Brien; A Burns
Journal:  Int J Geriatr Psychiatry       Date:  2001-07       Impact factor: 3.485

Review 2.  Managing comorbidities in patients at the end of life.

Authors:  James Stevenson; Amy P Abernethy; Cathy Miller; David C Currow
Journal:  BMJ       Date:  2004-10-16

3.  Reconsidering medication appropriateness for patients late in life.

Authors:  Holly M Holmes; Déon Cox Hayley; G Caleb Alexander; Greg A Sachs
Journal:  Arch Intern Med       Date:  2006-03-27

4.  Contribution of a liaison clinical pharmacist to an inpatient palliative care unit.

Authors:  C Lucas; P A Glare; J V Sykes
Journal:  Palliat Med       Date:  1997-05       Impact factor: 4.762

Review 5.  Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine.

Authors:  M H Beers; J G Ouslander; I Rollingher; D B Reuben; J Brooks; J C Beck
Journal:  Arch Intern Med       Date:  1991-09

Review 6.  Drug use in the nursing home.

Authors:  J Avorn; J H Gurwitz
Journal:  Ann Intern Med       Date:  1995-08-01       Impact factor: 25.391

Review 7.  Minimizing inappropriate medications in older populations: a 10-step conceptual framework.

Authors:  Ian A Scott; Leonard C Gray; Jennifer H Martin; Charles A Mitchell
Journal:  Am J Med       Date:  2012-03-03       Impact factor: 4.965

8.  The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes.

Authors:  I Schmidt; C B Claesson; B Westerholm; L G Nilsson; B L Svarstad
Journal:  J Am Geriatr Soc       Date:  1998-01       Impact factor: 5.562

9.  Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit.

Authors:  Kellie L Flood; Maria B Carroll; Cyndi V Le; Cynthia J Brown
Journal:  Am J Geriatr Pharmacother       Date:  2009-06

10.  Reducing the use of H2-receptor antagonists in the long-term-care setting.

Authors:  J H Gurwitz; J P Noonan; S B Soumerai
Journal:  J Am Geriatr Soc       Date:  1992-04       Impact factor: 5.562

View more
  45 in total

1.  Usually Available Clinical and Laboratory Data Are Insufficient for a Valid Medication Review: A Crossover Study.

Authors:  K P G M Hurkens; C Mestres-Gonzalvo; H A J M de Wit; P H M van der Kuy; R Janknegt; F Verhey; J M G A Schols; C D A Stehouwer; B Winkens; W Mulder
Journal:  J Nutr Health Aging       Date:  2016-01       Impact factor: 4.075

Review 2.  Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis.

Authors:  Tim Johansson; Muna E Abuzahra; Sophie Keller; Eva Mann; Barbara Faller; Christina Sommerauer; Jennifer Höck; Christin Löffler; Anna Köchling; Jochen Schuler; Maria Flamm; Andreas Sönnichsen
Journal:  Br J Clin Pharmacol       Date:  2016-05-07       Impact factor: 4.335

Review 3.  Deprescribing in Older Nursing Home Patients: Focus on Innovative Composite Measures for Dosage Deintensification.

Authors:  Sherrie L Aspinall; Joseph T Hanlon; Joshua D Niznik; Sydney P Springer; Carolyn T Thorpe
Journal:  Innov Aging       Date:  2017-12-20

Review 4.  Deprescribing for older patients.

Authors:  Christopher Frank; Erica Weir
Journal:  CMAJ       Date:  2014-09-02       Impact factor: 8.262

5.  Trends in the medication reviews of community pharmacies in Japan: a nationwide retrospective study.

Authors:  Toshihiro Koyama; Hiroshi Onoue; Ayako Ohshima; Yuri Tanaka; Yasuhisa Tatebe; Yoshito Zamami; Kazuaki Shinomiya; Yoshihisa Kitamura
Journal:  Int J Clin Pharm       Date:  2017-11-30

Review 6.  Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation.

Authors:  Fahad Shaikh; Lachlan B Pasch; Phillip J Newton; Beata V Bajorek; Caleb Ferguson
Journal:  Curr Cardiol Rep       Date:  2018-03-24       Impact factor: 2.931

7.  Patient-Reported Barriers and Facilitators to Deprescribing Cardiovascular Medications.

Authors:  Parag Goyal; Tatiana Requijo; Birgit Siceloff; Megan J Shen; Ruth Masterson Creber; Sarah N Hilmer; Ian M Kronish; Mark S Lachs; Monika M Safford
Journal:  Drugs Aging       Date:  2020-02       Impact factor: 3.923

8.  Recent Literature Update on Medication Risk in Older Adults, 2015-2016.

Authors:  Michael J Koronkowski; Todd P Semla; Kenneth E Schmader; Joseph T Hanlon
Journal:  J Am Geriatr Soc       Date:  2017-03-28       Impact factor: 5.562

9.  A pilot study of a Medication Rationalization (MERA) intervention.

Authors:  Rachel Whitty; Sandra Porter; Kiran Battu; Pranjal Bhatt; Ellen Koo; Csilla Kalocsai; Peter Wu; Kendra Delicaet; Isaac I Bogoch; Robert Wu; James Downar
Journal:  CMAJ Open       Date:  2018-02-16

10.  Potentially inappropriate drug prescribing in elderly hospitalized patients: an analysis and comparison of explicit criteria.

Authors:  Concetta Di Giorgio; Alessio Provenzani; Piera Polidori
Journal:  Int J Clin Pharm       Date:  2016-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.